Bellevue Group reported a 6.6% stake in Viridian Therapeutics, Inc.\DE VRDN · 6,726,144 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 6.6%
Last report: First report
Shares held: 6,726,144 sh
Class: Common Stock
Stock: Viridian Therapeutics, Inc.\DE VRDN
Holder: Bellevue Group
Event date: 26/03/31
Filed: 26/05/15

First 5%+ report · 6.6% stake

Viridian Therapeutics, Inc.\DE trades, last 26 weeks

What else happened in Viridian Therapeutics, Inc.\DE around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Bellevue Group's other 5% stake reports

Bellevue Group
5% stakeJade Biosciences
5% stake
Jade Biosciences
JBIO
5% stake
3,057,996 sh
5% stake
Filed 08/14
Bellevue Group
5% stakeCelldex Therapeutics
5% stake
Celldex Therapeutics
CLDX
1.5% stake
1,200,000 sh
1.5% stake
Filed 05/15
Bellevue Group
5% stakeJade Biosciences
5% stake
Jade Biosciences
JBIO
6.8% stake
3,341,103 sh
6.8% stake
Filed 02/17
Bellevue Group
5% stakeMacrogenics
5% stake
Macrogenics
MGNX
0% stake
0 sh
0% stake
Filed 01/06
Bellevue Group
5% stakeAgios Pharmaceuticals
5% stake
Agios Pharmaceuticals
AGIO
0% stake
0 sh
0% stake
Filed 25/12/05

Bellevue Group reported a 6.6% stake in Viridian Therapeutics, Inc.\DE VRDN · 6,726,144 sh · passive holder | Whalegun